Nanomix Granted CE Mark for Its eLab S1 Assay Panel for Whole Blood Samples

Emeryville, Calif.-based Nanomix has gained CE mark certification for its eLab S1 assay panel for use with whole blood samples.

The new certification enables faster results than the company’s previously CE-marked plasma-based panel by eliminating the need for centrifuging blood to produce a plasma sample.

The assay, which is intended as an aid in rapidly diagnosing infections, including sepsis, runs on the company’s eLab Analyzer, a mobile, hand-held immunoassay and chemistry diagnostic system designed for rapid point-of-care testing. The analyzer delivers results within approximately 12 minutes.

The eLab S1 panel provides quantitative test results for procalcitonin (PCT), C-reactive protein and lactate from a single plasma or whole blood sample.  It is “the first mobile, point-of-care product on the market that uses whole blood for PCT, one of the most important diagnostics used by providers while diagnosing critical infections and informing antibiotic treatment,” the company said.